Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Credit agrmnt [a]
Appointed director
Inv. presentation
Quarterly results
Acq. announced
Director departure
|
|
Bausch Health Companies Inc. (BHC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/31/2018 |
8-K
| Appointed a new director|
Docs:
|
"DR. ANDREW C. VON ESCHENBACH JOINS BAUSCH HEALTH BOARD OF DIRECTORS LAVAL, Quebec, October 30, 2018 – Bausch Health Companies Inc. today announced its board of directors has elected Dr. Andrew C. von Eschenbach to serve as a director, effective Oct. 29, 2018. With the addition of Dr. von Eschenbach, Bausch Health has a total of 11 members on its board, 10 of whom are independent. "I am pleased to welcome Dr. Andrew von Eschenbach to the Bausch Health board of directors," said Joseph C. Papa, chairman and CEO, Bausch Health. "Andy’s multiple roles throughout his distinguished career, ranging from his service as commissioner of the U.S. Food and Drug Administration and as director of the National Cancer Institute to his more than 25 years at the University of Texas MD Anderson Cancer Center..." |
|
| 07/28/2016 |
8-K
| Form 8-K - Current report |
| 10/26/2015 |
8-K
| Appointed a new director |
| 04/29/2015 |
8-K
| Appointed a new director |
|
|